Introduction: Numerous studies have reported alterations in the composition of gut microbiota in patients with acute ischemic stroke (AIS), with changes becoming more pronounced as the disease progresses. However, the association between the progression of transient ischemic attack (TIA) and AIS remains unclear. This study aims to elucidate the microbial differences among TIA, AIS, and healthy controls (HC) while exploring the associations between disease progression and gut microbiota.

Methods: Fecal samples were collected from acute TIA patients ( = 28), AIS patients ( = 235), and healthy controls ( = 75) and analyzed using 16 s rRNA gene sequencing. We determined characteristic microbiota through linear discriminant analysis effect size and used the receiver operating characteristic (ROC) curve to assess their predictive value as diagnostic biomarkers.

Results: Our results showed significant gut microbial differences among the TIA, AIS, and HC groups. Patients with AIS exhibited higher abundances of and along with lower abundances of and _UCG-004. Further analysis revealed that the abundance of characteristic bacteria, such as and , was negatively correlated with HDL levels, while was positively correlated with risk factors such as homocysteine (Hcy). In contrast, the abundance of _UCG-004 was negatively correlated with both Hcy and D-dimer levels. ROC models based on the characteristic bacteria and effectively distinguished TIA from AIS, yielding areas under the curve of 0.699 and 0.626, respectively.

Conclusion: We identified distinct changes in gut bacteria associated with the progression from TIA to AIS and highlighted specific characteristic bacteria as predictive biomarkers. Overall, our findings may promote the development of microbiome-oriented diagnostic methods for the early detection of AIS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11582031PMC
http://dx.doi.org/10.3389/fnagi.2024.1451968DOI Listing

Publication Analysis

Top Keywords

tia ais
20
characteristic bacteria
12
ais
9
acute ischemic
8
ischemic stroke
8
microbial differences
8
differences tia
8
healthy controls
8
negatively correlated
8
tia
6

Similar Publications

Background: Patients with acute ischemic stroke (AIS) in the setting of atrial fibrillation (Afib) will need to start/resume anticoagulation (AC) as it is the mainstay for secondary stroke prevention. Several studies have compared the safety and outcomes of starting/resuming AC in early or late start windows (ESW or LSW) but there is no consensus in clinical practice on the optimal timing of anticoagulation. This meta-analysis aims to compare the safety and outcome measures after resuming AC in the ESW versus LSW in patients with Afib after AIS.

View Article and Find Full Text PDF

Background And Purpose: Emerging evidence indicates lasting impairments in patients with transient ischaemic attack (TIA), which may be unexpected as symptoms per definition recover within 24 h. How these impairments impact return to work or the ability to maintain independence is unknown. The aim of our study was to investigate the need of sick leave or homecare following TIA compared with acute ischaemic stroke (AIS).

View Article and Find Full Text PDF

Introduction: Numerous studies have reported alterations in the composition of gut microbiota in patients with acute ischemic stroke (AIS), with changes becoming more pronounced as the disease progresses. However, the association between the progression of transient ischemic attack (TIA) and AIS remains unclear. This study aims to elucidate the microbial differences among TIA, AIS, and healthy controls (HC) while exploring the associations between disease progression and gut microbiota.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the effectiveness of various antithrombotic treatments for nonvalvular atrial fibrillation patients who had acute ischemic strokes with large artery atherosclerosis mechanisms.
  • An analysis of clinical data from 501 patients revealed that those with competing LAA mechanisms had better short-term outcomes but still faced higher risks of ischemic events.
  • Findings suggest that while the optimal antithrombotic regimen isn't clearly defined, the underlying stroke mechanisms are crucial for determining treatment strategies.
View Article and Find Full Text PDF

Background: Many studies evaluated the efficacy and safety of ticagrelor versus clopidogrel in patients with ischemic stroke; none of these trials included North African participants, and all of these trials comprised only participants who experienced transient ischemic attack (TIA) or minor stroke.

Objectives: We compared the efficacy and safety of ticagrelor versus clopidogrel in patients with first-ever noncardioembolic moderate or moderate-to-severe ischemic stroke.

Methods: Our trial involved 900 first-ever noncardioembolic patients with acute ischemic stroke (AIS) who randomly received either loading and maintenance doses of ticagrelor or clopidogrel within the first 24 h of stroke onset.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!